Skip to main content
. 2022 Oct 6;83:104526. doi: 10.1016/j.amsu.2022.104526

Table 1.

Data analysis.

Variable Cases of Internal jugular vein thrombosis
Sex, n(%)
male 24 (42.11%)
female 33 (57.89%)
Mean age, years (range) 50.2 (16–88)
Investigations used, n (%)
US 11 (19.29%)
CT 13 (22.08%)
MRI 2 (3.50%)
US + CT 21 (36.84%)
US + CT + MRI 2 (3.50%)
CT + FDG PET 1 (1.75%)
US + MRI 2 (3.50%)
MRI + Angiography 1 (1.75%)
Veinography + US 1 (1.75%)
Not specified 2 (3.50%)
CT + MRI 1 (1.75%)
Location of IJV thrombosis n, (%) 23 (40.35%)
Left IJV 23 (40.35%)
Right IJV 7 (12.28%)
Bilateral IJV 4 (7.01%)
Not specified 6 (10.52%)
Involvement of other veins n, (%) 2 (3.50$)
Subclavian vein 1 (1.75%)
Subclavian and brachiocephalic 1 (1.75%)
Subclavian and axillary 1 (1.75%)
Subclavian, axillary, and humeral 1 (1.75%)
External jugular 1 (1.75%)
External Jugular and brachiocephalic 1 (1.75%)
Sigmoid sinus 42 (73.68%)
Transverses and sigmoid sinus 19 (33.33%)
None 2 (3.50%)
Associated Factors n, (%) Malignancy 1 (1.75%)
Antiphospholipid syndrome 1 (1.75%)
Homozygous factor V Leiden Mutation, activated factor C resistance and Dengue fever 1 (1.75%)
Homozygous MTHFR mutation and protein C deficiency Protein S deficiency 1 (1.75%)
Septic Pneumonia and HIT 1 (1.75%)
Liver Transplant Ovarian hyperstimulation syndrome 2 (3.50%)
Nephrotic Syndrome 1 (1.75%)
Nitrous Oxide abuse 1 (1.75%)
Hypothyroidism 1 (1.75%)
Substernal Goiter 1 (1.75%)
Laryngeal surgery 1 (1.75%)
None 22 (38.59%)
Clinical Presentation Case of IJV thrombosis
Neck Swelling 25 (43.85%)
Asymptomatic 4 (7.05%)
Neck Pain 5 (8.77%)
Swelling of the supraclavicular fossa 1 (1.75%)
Chest pain 2 (3.50%)
Facial and upper limb swelling 2 (3.50%)
Swelling of the parotid gland 1 (1.75%)
Fever and dyspnea 2 (3.50%)
Dizziness 1 (1.75%)
Hoarseness 1 (1.75%)
Confusion and fall 1 (1.75%)
Septic shock and encephalopathy 1 (1.75%)
Exacerbation of COPD 1 (1.75%)
Complication Cases of IJV thrombosis
No complication 48 (84.21%)
Death 2 (3.50%)
Peripheral facial palsy 1 (1.75%)
Pulmonary embolism 2 (3.50%)
Pulmonary HTN 1 (1.75%)
Not specified 3 (5.26%)